Enteral formulas, which are used to feed hospitalized patients, have been an important achievement in science and medicine. Enteral tube feeding is the standard nutritional support, for patients with a functioning gastrointestinal tract. Expanding knowledge of the role of nutrients in various diseases has prompted the development of specialized nutrients for patients with specific disease. Enteral feeding is a method of providing nutrients directly into the gastrointestinal (GI) tract when a person cannot receive food orally. It is used in patients who have an adequate functional GI tract and can digest and absorb food but in whom oral intake is inadequate to maintain or restore optimal nutritional status. Also known as tube feeding, enteral nutrition (EN) delivers nutrients directly to the stomach or intestines through a thin flexible tube
The Germany enteral feeding formulas market is anticipated to grow in the forecast, owing to high prevalence of chronic diseases and disorders as well as increasing demand for homecare. A according to the data from the World Health Organization, 37% of deaths in Germany were due to cardiovascular diseases in the year 2017. In the same year, 26% of total deaths were occurred due to various cancers whereas, chronic respiratory diseases caused 6% of total deaths in 2017. These statistics indicate the chronic diseases are having a larger contribution to the mortality rate of the German population Rise in premature births is one of the key factors propelling demand for sip feeds to cater to the nutritional requirements of the new-borns. Increasing evolution in technology and product innovation is another key factor positively impacting the growth of tube feeds.
Amid COVID-19 pandemic intensive care units worldwide have become overwhelmed with the severe acute respiratory syndrome. The nutritional management of the ICU patient with COVID-19 is on basic level similar to any other ICU patient admitted with respiratory disorder. The increasing need for nutrition management in critical care is expected to drive the growth of the enteral feeding formulas market.
Enteral feeding formula manufacturers, like all others, should adjust to manage the worldwide pandemic and there will unavoidably be interruption in the supply chain. This is driving nutrition companies to look for contingency courses of action and to better understand their supply chains and vulnerabilities.
The report analyses the global enteral feeding formulas market based on product, age group, application and end user.
The various products of enteral feeding formulas that are commercially available in German marketplace includes standard formulas, peptide formulas and specialized formulas. In 2020, the standard formula segment held the largest share of the enteral feeding formulas and is expected to maintain its lead over the forecast period owing to its high usage for enteral nutrition, high commercial availability, and growing investment by major market players. The wide availability of different varieties of standard formulas, along with increasing demand for low-cost nutrient formulations, further boosts the segment growth.
These formulas are used across populace of various age group including adults and paediatrics. Adults segment is likely to have maximum demand for the enteral feeding formulas market. Mostly, enteral nutrition is prescribed to patients suffering from malnutrition, cancer or gastrointestinal disorders. Increasing prevalence of chronic diseases and illness such as neurological diseases and disorders in adults are which are driving the market in adults.
The oncology segment held the largest market share of the enteral feeding formula, primarily due to high prevalence of malnutrition among cancer patients. Around 1.7 million people living in Germany have been diagnosed with cancer within the last 5 years. Tobacco consumption is the most important risk factor increasing the prevalence of cancer in Germany. Cancer patients are prone to severe malnutrition induced by the tumour or its associated therapy including tumour removal surgeries, radiations and chemotherapy which in turn surge the demand for tube feeding for nutritional support. Manufacturers develop formulas to specifically target the cancer associated conditions, thereby increasing the adoption of enteral feeding formulas among cancer patients.
The major end users of the market are hospitals, ambulatory surgical centres and home care. Homecare segment had a momentous revenue share in 2020 and it is likely to grow at a fastest pace. The homecare segment is growing attributed to the factors such as advancement in enteral feeding formula, increasing preference for enteral feeding tubes by geriatric population as point-of-care device at home due to ease and convenience offered by enteral feeding formula..
March 2019: Danone opened a new sustainable Nutrica plant in the Netherlands to meet growing global demand for specialized infant formula. This plant will produce highly specialized infant formula-including formula for specific health conditions and employ close to 500 employees once fully operational.
January 2017: Nestlé Health Science introduced new Compleat family of tube-feeding formulas for adults and children. The three formulas including compleat, compleat pediatric and compleat pediatric reduced calorie include a variety of ingredients from real foods, plus vitamins, minerals, and other nutrients.
The report analyses the global enteral feeding formulas market based on product, age, application and end user. The various enteral feeding formulas studied in this report are standard formulas, peptide formulas and specialized formulas. These formulas are used across populace of various age group including adults and paediatrics. The market finds application in neurology, critical care, diabetes, gastro enterology and other applications. The major end users of these products are hospitals, home care, ambulatory surgical centers (ASCs) etc.
The key competitors of this market include Abbott Laboratories (U.S.), Nestlé S.A. (Switzerland), Danone S.A. (France), Fresenius Kabi AG (Germany), Mead Johnson Nutrition Company (U.S.), B. Braun Melsungen AG (Germany), Hormel Foods, LLC (U.S.), Victus Inc. (U.S.), Meiji Holdings Co., Ltd. (Japan), and Global Health Product Inc. (U.S.), Nutricia (Netherlands), and Aveanna Healthcare (U.S). among others.
Why to buy this report: